Neoprobe hires Troup to aid biotech evolution
This article was originally published in Clinica
Gordon Troup has joined the board of directors at Neoprobe (Dublin, Ohio), a company that makes gamma detection and blood flow measurement devices, as well as some pharmaceutical products. Mr Troup was most recently the president of Cardinal Health’s nuclear pharmacy services unit, a position he held for 17 years. Mr Troup’s business and marketing expertise will be used by Neoprobe as it launches itself into the biotech sector –to cover drug products as well as its ongoing device product lines.